Stereotactic body radiation therapy for treatment of soft tissue sarcomas in 35 dogs.

Objective: To describe response rate, tumor progression, patient survival times, prognostic factors associated with tumor progression and patient survival times, and radiation toxicoses (acute and latent) in dogs treated with curative-intent stereotactic body radiation therapy (SBRT) for soft tissue sarcomas (STS).

Animals: 35 client-owned dogs with STS treated with curative-intent SBRT between October 2011 and May 2017.

Procedures: Medical records were reviewed to identify dogs that underwent SBRT.